News
Media
Conferences
Publication
Job Board
CME/CE
Partners
Editorial
Resources
Subscribe

Spotlight -

Long-Acting Injectable Therapy in the Management of Adult Patients with Schizophrenia|

Major Depressive Disorder

|Videos|February 4, 2022

DSM-V Diagnostic Criteria for Sleep Disorders

Experts in sleep disorders review the DSM-V Diagnostic Criteria for insomnia disorder and discuss sleep disorder permutations.

Episodes in this series

EP. 1 Overview and Incidence of Insomnia Disorder

EP. 1 Overview and Incidence of Insomnia Disorder

EP. 2 DSM-V Diagnostic Criteria for Sleep Disorders

EP. 2 DSM-V Diagnostic Criteria for Sleep Disorders

EP. 3 Overview of Parasomnias

EP. 3 Overview of Parasomnias

EP. 4 Treatments for Parasomnia and Sleep Disorders

EP. 4 Treatments for Parasomnia and Sleep Disorders

EP. 5 Disorders and COVID-19

EP. 5 Disorders and COVID-19

EP. 6 Insomnia: Treatment and Management Considerations

EP. 6 Insomnia: Treatment and Management Considerations

EP. 7 Insomnia Clinical Practice Pearls

EP. 7 Insomnia Clinical Practice Pearls

Newsletter

Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.

Related Content

fibromyalgia tonmya available

Tonmya Available Commercially for Treatment of Fibromyalgia

ByJessica Walters

November 18th 2025

stroke

Beyond Survival: Understanding the Long Road to Stroke Recovery

ByMatthew Ashley, MD, JD

October 29th 2025

visuals6x/adobestock

International Stuttering Awareness Day: Why Psychiatrists Should Pay Attention

ByGerald A. Maguire, MD,Heidi Anne Duerr, MPH

October 22nd 2025

precision

Precision Diagnosis: The New Paradigm for Neurocognitive Disorders

BySehba Husain-Krautter MD, PhD,James M. Ellison, MD, MPH

October 20th 2025

brains

Recognizing the Neuropsychiatric Symptoms of Huntington Disease

ByMuhammad J. Saadah, BA, MPH,Nidal Moukaddam, MD, PhD

October 10th 2025

Latest CME

Southern Florida Psychiatry Conference

In-Person Event

Southern Florida Psychiatry Conference

November 21-22, 2025

SimulatED™: Understanding the Role of Genetic Testing in Patient Selection for Anti-Amyloid Therapy

Case-based Simulation

SimulatED™: Understanding the Role of Genetic Testing in Patient Selection for Anti-Amyloid Therapy

Nicholas Doher, DO; Babak Tousi, MD

Real Psychiatry 2026

In-Person + Virtual Event

Real Psychiatry 2026

January 23-24, 2026

Managing Negative Symptoms of Schizophrenia: Can Prescription Digital Therapeutics Make an Impact?

Managing Negative Symptoms of Schizophrenia: Can Prescription Digital Therapeutics Make an Impact?

Michael Asbach, DMSc, PA-C; Erin Crown, MHS, PA-C, Psych-CAQ

Optimizing Care for Patients With Tardive Dyskinesia

Optimizing Care for Patients With Tardive Dyskinesia

Amber Hoberg, MSN, APRN, PMHNP-BC; Erin Crown, PA-C, Psych-CAQ

Stabilize and Thrive: Prioritizing Patient Success Through Novel Therapeutic Management in Schizophrenia

Stabilize and Thrive: Prioritizing Patient Success Through Novel Therapeutic Management in Schizophrenia

Jonathan Meyer, MD; Jacob Hanaie, PharmD, APh, BCPP; Sanjai Rao, MD, DFAPA

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Jason Kellogg, MD; Gus Alva, MD, DFAPA; Melanie Barrett, MD; Yvette Elpidio, MSN, FNP-C

(CME Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

(CME Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Gus Alva, MD, DFAPA; Ilan Melnick, MD

(Pharmacist Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

(Pharmacist Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Gus Alva, MD, DFAPA; Ilan Melnick, MD

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Jason Kellogg, MD; Gus Alva, MD, DFAPA; Melanie Barrett, MD; Yvette Elpidio, MSN, FNP-C

Trending on Psychiatric Times

Improving Outcomes in Schizophrenia With Long-Acting Injectables: Insights from the Southern Florida Psychiatry Conference

Prescription Digital Therapeutics: Transforming Health Care Delivery

The Future of ADHD Care: Redefining Adult Diagnosis and Treatment

Tolerance to Stimulant Medications in the Treatment of Children With ADHD

Benefits of Long-Acting Injectable Antipsychotics: An Overview From Southern Florida Psychiatry Conference

© 2025 MJH Life Sciences^®

All rights reserved.